2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
20
Lymphoma, B-Cell
19
Lymphoma, Large B-Cell, Diffuse
18
Recurrence
13
Lymphoma, Non-Hodgkin
13
Multiple Myeloma
12
Burkitt Lymphoma
11
Lymphoma, Mantle-Cell
8
Lymphoma
8
Leukemia, Myeloid, Acute
8
Carcinoma, Hepatocellular
7
Pancreatic Neoplasms
6
Neoplasms
6
Lymphoma, Follicular
6
Leukemia, Lymphocytic, Chronic, B-Cell
6
Leukemia
5
Glioma
5
Colorectal Neoplasms
5
Stomach Neoplasms
4
Leukemia, B-Cell
4
Hematologic Neoplasms
4
Neoplasm, Residual
3
Nasopharyngeal Carcinoma
3
Melanoma
3
Esophageal Neoplasms
3
Breast Neoplasms
3
Simpson-Golabi-Behmel syndrome
2
Sarcoma, Synovial
2
Sarcoma, Ewing
2
Rhabdomyosarcoma
2
Interventions
Cyclophosphamide
32
Etoposide
18
romidepsin
17
fludarabine
17
Vincristine
17
Doxorubicin
16
Rituximab
14
Prednisone
14
Melphalan
14
Gemcitabine
13
Brentuximab Vedotin
13
Lenalidomide
12
Peripheral Blood Stem Cell Transplantation
11
Cytarabine
11
Whole-Body Irradiation
10
Biopsy
10
10-propargyl-10-deazaaminopterin
10
pembrolizumab
9
fludarabine phosphate
9
Specimen Handling
9
Busulfan
9
Mycophenolic Acid
8
Granulocyte Colony-Stimulating Factor
8
Depsipeptides
8
Carmustine
8
Bortezomib
8
duvelisib
7
Vorinostat
7
Methotrexate
7
Magnetic Resonance Spectroscopy
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lymphoma, T-Cell
×
Immunotherapy, Adoptive
×
Clear all
NCT01685606
2022-03-04
273
Brown University
Phase 2
Terminated
6 enrolled
7 charts